Cargando…
Severe Eosinophilic Asthma
Asthma is a heterogeneous disease with varying severity. Severe asthma is a subject of constant research because it greatly affects patients’ quality of life, and patients with severe asthma experience symptoms, exacerbations, and medication side effects. Eosinophils, although at first considered in...
Autores principales: | Bakakos, Agamemnon, Loukides, Stelios, Bakakos, Petros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780074/ https://www.ncbi.nlm.nih.gov/pubmed/31480806 http://dx.doi.org/10.3390/jcm8091375 |
Ejemplares similares
-
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021) -
Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016) -
Biological Therapy of Severe Asthma and Nasal Polyps
por: Bakakos, Agamemnon, et al.
Publicado: (2022) -
Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023) -
Unraveling the Relationship of Asthma and COVID-19
por: Bakakos, Agamemnon, et al.
Publicado: (2021)